Department of Medical Physics, ProCure Proton Therapy Center, Somerset NJ 08873, USA.
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Med Dosim. 2022;47(1):26-31. doi: 10.1016/j.meddos.2021.07.003. Epub 2021 Aug 21.
Deep inspiration breath hold (DIBH) has dosimetric advantages for lung cancer patients treated with external beam therapy, but is difficult for many patients to perform. Proton therapy permits sparing of the downstream organs at risk (OAR). We compared conventionally fractionated proton (p) and photon(x) plans on both free breathing (FB) and DIBH planning CTs to determine the effect of DIBH with proton therapy. We evaluated 24 plans from 6 lung cancer patients treated with photon DIBH on a prospective protocol. All patients were re-planned using pencil beam scanning (PBS) proton therapy. New plans were generated for FB datasets with both modalities. All plans were renormalized to 60 Gy. We evaluated dosimetric parameters for heart, lung and esophagus. We also compared FB to DIBH parameters to quantify how FB plans compare to DIBH plans. Significant differences were found for lung metrics V20 and mean lung dose between FB and DIBH plans regardless of treatment modality. Furthermore, lung metrics for FB were comparable or superior to DIBH, suggesting that FB protons may be a viable alternative for those patients that cannot perform DIBH with IMRT. The heart dose metrics were significantly different for the 5 out of 6 patients where the PTV overlapped the heart as DIBH moved heart out of the high dose volume. Heart dose metrics were further reduced by proton therapy. DIBH offers similar relative advantages for lung sparing for PBS as it does for IMRT but the magnitude of the DIBH related gains in OAR sparing were smaller for PBS than IMRT. FB plans offer similar or better lung and heart sparing compared to DIBH plans. For IMRT patients who have difficulty performing DIBH, FB protons may offer an alternative.
深吸气屏气(DIBH)对外照射治疗肺癌患者具有剂量学优势,但对许多患者来说难以实施。质子治疗可以使下游危及器官(OAR)免受照射。我们比较了常规分割质子(p)和光子(x)计划在自由呼吸(FB)和 DIBH 计划 CT 上的剂量学差异,以确定质子治疗中 DIBH 的效果。我们评估了 6 例接受光子 DIBH 治疗的肺癌患者的 24 个计划,这些患者均参加了前瞻性协议。所有患者均使用笔束扫描(PBS)质子治疗重新进行计划。两种模式均为 FB 数据集生成新计划。所有计划均归一化为 60Gy。我们评估了心脏、肺和食管的剂量学参数。我们还比较了 FB 与 DIBH 参数,以量化 FB 计划与 DIBH 计划的比较。无论治疗方式如何,FB 和 DIBH 计划之间的肺参数 V20 和平均肺剂量均存在显著差异。此外,FB 肺参数与 DIBH 相当或优于 DIBH,这表明对于无法进行 IMRT 的 DIBH 的患者,FB 质子可能是一种可行的替代方案。对于 6 例 PTV 与心脏重叠的患者,DIBH 可使心脏离开高剂量区,因此心脏剂量学参数存在显著差异。质子治疗进一步降低了心脏剂量学参数。DIBH 为 PBS 提供了与 IMRT 相似的相对优势,可使肺免受照射,但 PBS 比 IMRT 对 OAR 保护的 DIBH 相关增益幅度较小。与 DIBH 计划相比,FB 计划提供了相似或更好的肺和心脏保护。对于难以进行 DIBH 的 IMRT 患者,FB 质子可能是一种替代方案。